Clinical Significance of Neoadjuvant Chemotherapy With Gemcitabine Plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma

Background/Aim: Little is known about the efficacy of neoadjuvant chemotherapy (NAC) with gemcitabine plus S-1 (GS) for patients with resectable pancreatic ductal adenocarcinoma (R-PDAC). The aim of this study was to investigate differences in the long-term outcome of patients with R-PDAC undergoing...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:In Vivo
Egile Nagusiak: SUZUKI, TAKASHI, MORI, SHOZO, SHIMIZU, TAKAYUKI, TAGO, KAZUMA, HARADA, NOBUHIRO, PARK, KYUNG-HWA, SAKURAOKA, YUHKI, SHIRAKI, TAKAYUKI, ISO, YUKIHIRO, AOKI, TAKU, KUBOTA, KEIICHI
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: International Institute of Anticancer Research 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899096/
https://ncbi.nlm.nih.gov/pubmed/31662534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11700
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak